BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22539604)

  • 1. Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
    Fehringer G; Liu G; Pintilie M; Sykes J; Cheng D; Liu N; Chen Z; Seymour L; Der SD; Shepherd FA; Tsao MS; Hung RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1097-104. PubMed ID: 22539604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
    Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
    Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
    Zienolddiny S; Skaug V; Landvik NE; Ryberg D; Phillips DH; Houlston R; Haugen A
    Carcinogenesis; 2009 Aug; 30(8):1368-71. PubMed ID: 19465454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk.
    Falvella FS; Galvan A; Frullanti E; Spinola M; Calabrò E; Carbone A; Incarbone M; Santambrogio L; Pastorino U; Dragani TA
    Clin Cancer Res; 2009 Mar; 15(5):1837-42. PubMed ID: 19223495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.
    Truong T; Hung RJ; Amos CI; Wu X; Bickeböller H; Rosenberger A; Sauter W; Illig T; Wichmann HE; Risch A; Dienemann H; Kaaks R; Yang P; Jiang R; Wiencke JK; Wrensch M; Hansen H; Kelsey KT; Matsuo K; Tajima K; Schwartz AG; Wenzlaff A; Seow A; Ying C; Staratschek-Jox A; Nürnberg P; Stoelben E; Wolf J; Lazarus P; Muscat JE; Gallagher CJ; Zienolddiny S; Haugen A; van der Heijden HF; Kiemeney LA; Isla D; Mayordomo JI; Rafnar T; Stefansson K; Zhang ZF; Chang SC; Kim JH; Hong YC; Duell EJ; Andrew AS; Lejbkowicz F; Rennert G; Müller H; Brenner H; Le Marchand L; Benhamou S; Bouchardy C; Teare MD; Xue X; McLaughlin J; Liu G; McKay JD; Brennan P; Spitz MR
    J Natl Cancer Inst; 2010 Jul; 102(13):959-71. PubMed ID: 20548021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans.
    Walsh KM; Gorlov IP; Hansen HM; Wu X; Spitz MR; Zhang H; Lu EY; Wenzlaff AS; Sison JD; Wei C; Lloyd SM; Chen W; Frazier ML; Seldin MF; Bierut LJ; Bracci PM; Wrensch MR; Schwartz AG; Wiencke JK; Amos CI
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):251-60. PubMed ID: 23221128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population.
    Ito H; McKay JD; Hosono S; Hida T; Yatabe Y; Mitsudomi T; Brennan P; Tanaka H; Matsuo K
    J Thorac Oncol; 2012 May; 7(5):790-8. PubMed ID: 22430809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
    Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
    Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis for susceptibility to lung cancer: Recent progress and future directions.
    Yokota J; Shiraishi K; Kohno T
    Adv Cancer Res; 2010; 109():51-72. PubMed ID: 21070914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
    Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
    Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung.
    Nguyen JD; Lamontagne M; Couture C; Conti M; Paré PD; Sin DD; Hogg JC; Nickle D; Postma DS; Timens W; Laviolette M; Bossé Y
    Carcinogenesis; 2014 Dec; 35(12):2653-9. PubMed ID: 25187487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers.
    Välk K; Vooder T; Kolde R; Reintam MA; Petzold C; Vilo J; Metspalu A
    Oncology; 2010; 79(3-4):283-92. PubMed ID: 21412013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.
    de Mello RA; Ferreira M; Soares-Pires F; Costa S; Cunha J; Oliveira P; Hespanhol V; Reis RM
    PLoS One; 2013; 8(9):e72373. PubMed ID: 24039754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.
    Yoon KA; Jung MK; Lee D; Bae K; Joo JN; Lee GK; Lee HS; Lee JS
    Clin Cancer Res; 2014 Jun; 20(12):3272-9. PubMed ID: 24737549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.